Huntingtin-Lowering Therapies for Huntington Disease-Reference-Cited by-同舟云学术

Huntingtin-Lowering Therapies for Huntington Disease

Published:2020-06-01 Issue:6 Volume:77 Page:764
ISSN:2168-6149
Container-title:JAMA Neurology
language:en
Short-container-title:JAMA Neurol

Author:

Leavitt Blair R.¹,Kordasiewicz Holly B.²,Schobel Scott A.³

Affiliation:

1. Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, BC Children’s Hospital, University of British Columbia, Vancouver, British Columbia, Canada

2. Ionis Pharmaceuticals, Carlsbad, California

3. F. Hoffmann-La Roche Ltd, Basel, Switzerland

Publisher

American Medical Association (AMA)

Subject

Neurology (clinical)

Link

https://jamanetwork.com/journals/jamaneurology/articlepdf/2763342/jamaneurology_leavitt_2020_bs_200001.pdf

Reference48 articles.

1. Huntington disease.;Bates;Nat Rev Dis Primers,2015

2. Huntington disease: a clinical review.;Roos;Orphanet J Rare Dis,2010

3. Huntington disease: natural history, biomarkers and prospects for therapeutics.;Ross;Nat Rev Neurol,2014

4. The HTT CAG-expansion mutation determines age at death but not disease duration in Huntington disease.;Keum;Am J Hum Genet,2016

5. Homozygosity for CAG mutation in Huntington disease is associated with a more severe clinical course.;Squitieri;Brain,2003

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacokinetics and pharmacodynamics of PTC518, an oral huntingtin lowering splicing modifier: A first‐in‐human study;British Journal of Clinical Pharmacology;2024-08-18

2. The Brain–Gut–Bone Axis in Neurodegenerative Diseases: Insights, Challenges, and Future Prospects;Advanced Science;2024-08-09

3. Perillaldehyde alleviates polyQ‐induced neurodegeneration through the induction of autophagy and mitochondrial UPR in Caenorhabditis elegans;BioFactors;2024-07-11

4. Liposomes as versatile agents for the management of traumatic and nontraumatic central nervous system disorders: drug stability, targeting efficiency, and safety;Neural Regeneration Research;2024-07-10

5. Sequencing-guided design of genetically encoded small RNAs targeting CAG repeats for selective inhibition of mutant huntingtin;Molecular Therapy - Nucleic Acids;2024-06